These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33351090)

  • 1. Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients.
    de Vries S; Schaapveld M; Janus CPM; Daniëls LA; Petersen EJ; van der Maazen RWM; Zijlstra JM; Beijert M; Nijziel MR; Verschueren KMS; Kremer LCM; van Eggermond AM; Lugtenburg PJ; Krol ADG; Roesink JM; Plattel WJ; van Spronsen DJ; van Imhoff GW; de Boer JP; Aleman BMP; van Leeuwen FE
    J Natl Cancer Inst; 2021 Jun; 113(6):760-769. PubMed ID: 33351090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
    Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
    J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population.
    Núñez-García B; Clemente MB; Sánchez JC; Royuela A; Ibargüen BCS; Méndez M; López-Ibor JV; Martínez M; Traseira C; Garitaonaindia Y; Aguado R; Calvo V; Torrente M; Parejo C; Provencio Z; Provencio M
    Hematol Oncol; 2023 Aug; 41(3):407-414. PubMed ID: 36934306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
    van Eggermond AM; Schaapveld M; Janus CP; de Boer JP; Krol AD; Zijlstra JM; van der Maazen RW; Kremer LC; van Leerdam ME; Louwman MW; Visser O; De Bruin ML; Aleman BM; van Leeuwen FE
    Br J Cancer; 2017 Jul; 117(3):306-314. PubMed ID: 28632726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.
    Castellino SM; Geiger AM; Mertens AC; Leisenring WM; Tooze JA; Goodman P; Stovall M; Robison LL; Hudson MM
    Blood; 2011 Feb; 117(6):1806-16. PubMed ID: 21037086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of male breast cancer after Hodgkin lymphoma.
    de Vries S; Krul IM; Schaapveld M; Janus CPM; Rademakers SE; Roesink JM; Nijziel MR; Bilgin YM; Aleman BMP; van Leeuwen FE
    Blood; 2023 Aug; 142(9):806-811. PubMed ID: 37390297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of second breast cancer in female Hodgkin's lymphoma survivors: a meta-analysis.
    Ibrahim EM; Abouelkhair KM; Kazkaz GA; Elmasri OA; Al-Foheidi M
    BMC Cancer; 2012 May; 12():197. PubMed ID: 22639888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
    Sud A; Thomsen H; Sundquist K; Houlston RS; Hemminki K
    J Clin Oncol; 2017 May; 35(14):1584-1590. PubMed ID: 28384078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.
    Krul IM; Boekel NB; Kramer I; Janus CPM; Krol ADG; Nijziel MR; Zijlstra JM; van der Maazen RWM; Roesink JM; Jacobse JN; Schaapveld M; Schmidt MK; Opstal-van Winden AWJ; Sonke GS; Russell NS; Aleman BMP; van Leeuwen FE
    Cancer; 2022 Dec; 128(24):4285-4295. PubMed ID: 36281718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.
    Neppelenbroek SIM; Geurts YM; Aleman BMP; Lugtenburg PJ; Rademakers SE; de Weijer RJ; Schippers MGA; Ta BDP; Plattel WJ; Zijlstra JM; van der Maazen RWM; Nijziel MR; Ong F; Schimmel EC; Posthuma EFM; Kersten MJ; Böhmer LH; Muller K; Koene HR; Te Boome LCJ; Bilgin YM; de Jongh E; Janus CPM; van Leeuwen FE; Schaapveld M
    J Clin Oncol; 2024 Jun; 42(16):1903-1913. PubMed ID: 38359378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis.
    Ibrahim EM; Kazkaz GA; Abouelkhair KM; Al-Mansour MM; Al-Fayea TM; Al-Foheidi M; Bayer AM; Elmasri OA
    Lung; 2013 Feb; 191(1):117-34. PubMed ID: 23053567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
    Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
    Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Hodgkin lymphoma: trade-offs between short- and long-term mortality risks.
    Yeh JM; Diller L
    Blood; 2012 Sep; 120(11):2195-202. PubMed ID: 22826564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
    De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Mortality Risk in the Recent Era in Early-Stage Hodgkin Lymphoma Patients Treated With Radiation Therapy With or Without Chemotherapy.
    Patel CG; Michaelson E; Chen YH; Silver B; Marcus KJ; Stevenson MA; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):498-506. PubMed ID: 29153331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
    N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.
    Bhuller KS; Zhang Y; Li D; Sehn LH; Goddard K; McBride ML; Rogers PC
    Br J Haematol; 2016 Mar; 172(5):757-68. PubMed ID: 26727959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study.
    Elkin EB; Klem ML; Gonzales AM; Ishill NM; Hodgson D; Ng AK; Marks LB; Weidhaas J; Freedman GM; Miller RC; Constine LS; Myrehaug S; Yahalom J
    J Clin Oncol; 2011 Jun; 29(18):2466-73. PubMed ID: 21576642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
    van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
    JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.